STAAR SURGICAL CO — Form 8-K/A
Filed October 5, 2026 · analyzed by the 8-K Agent
8-K/A
▲ Likely positive
significance 58/100
What the filing says
David Bailey, former President/CEO of STAAR (2001–2008) and President of International Operations (2008–2011), joins as Chief Commercial Officer effective September 9, 2026, reporting to Warren Foust. Compensation package: $575,000 base salary, $850,000 initial equity grant (50% RSUs/50% options vesting over 3 years), $1,400,000 prorated 2026 long-term incentive award, and 60% annual bonus target. Bailey previously led ICL commercialization globally and secured 2005 FDA approval; international revenues grew from ~$32M in ICL (2011) to over $320M today.
Why this rating
Meaningful leadership hire ($2.8M+ year-one compensation = 0.3% of $883.9M market cap) with proven track record executing STAAR's core strategy. Not transformational but signals confidence in ICL growth trajectory versus declining laser market.
See more from October 5, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.